SCHEMBL29632010

SCHEMBL29632010

COc1ccc(C(=O)NC2CCC(Nc3cc(C(F)(F)F)nc4ccccc34)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK7 P49862 1/20 0.53
MCHR1 Q99705 5/20 0.52
ADRA2A P08913 4/20 0.52
IGF1R P08069 4/20 0.48
MAPT P10636 1/20 0.48
RAB9A P51151 3/20 0.47
HTT P42858 1/20 0.47
PAX8 Q06710 1/20 0.47
HTR1A P08908 1/20 0.46
ADRA1A P35348 1/20 0.46
HRH1 P35367 1/20 0.46
HTR2B P41595 1/20 0.46
NPY5R Q15761 1/20 0.46
NPC1 O15118 2/20 0.46
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ADORA3 P0DMS8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24494484 1.00 KLK7 (0.53) KLK7MCHR1ADRA2AIGF1RMAPT
SCHEMBL24359952 1.00 KLK7 (0.53) KLK7MCHR1ADRA2AIGF1RMAPT
SCHEMBL29522819 0.91 GRM5 (0.52) KLK7MCHR1ADRA2AIGF1RMAPT
SCHEMBL25111605 0.91 GRM5 (0.52) KLK7MCHR1ADRA2AIGF1RMAPT
SCHEMBL24360027 0.91 MCHR1 (0.55) KLK7MCHR1ADRA2AIGF1RNPC1
SCHEMBL29632192 0.91 MCHR1 (0.55) KLK7MCHR1ADRA2AIGF1RNPC1
SCHEMBL24360055 0.90 ADRA2A (0.56) MCHR1ADRA2AIGF1RHTR1AADRA1A
SCHEMBL30540340 0.90 MEN1 (0.55) MCHR1ADRA2AIGF1RMAPTRAB9A
SCHEMBL24360187 0.90 MEN1 (0.55) MCHR1ADRA2AIGF1RMAPTRAB9A
SCHEMBL24494374 0.89 KLK7 (0.52) KLK7MCHR1ADRA2AIGF1RMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12384748-B2 Modulators of mas-related g-protein receptor X2 and related products and methods ESCIENT PHARMACEUTICALS, INC. (US) 2025-08-12 US disclosed
US-20240351987-A1 MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS ESCIENT PHARMACEUTICALS INC (US) 2024-10-24 US disclosed
CN-116710434-A Modulators of MAS-related G protein receptor X2 and related products and uses thereof 伊赛恩特制药公司 2023-09-05 CN disclosed
EP-4232042-A1 MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND THEIR USE ESCIENT PHARMACEUTICALS, INC. (US) 2023-08-30 EP disclosed
WO-2022087083-A1 MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND THEIR USE ESCIENT PHARMACEUTICALS, INC. (US) 2022-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240351987-A1 MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS MRGPRX2, MRGPRX1, MRGPRX4 KLK7 1859/4885MCHR1 37/4885ADRA2A 133/4885
US-12384748-B2 Modulators of mas-related g-protein receptor X2 and related products and methods MRGPRX2, MRGPRX1, MRGPRX4 KLK7 1859/4885MCHR1 37/4885ADRA2A 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.